Pharmacodynamic substances and mechanism of Chelidonii Herba-Corydalis Rhizoma against estrogen receptor-positive breast cancer / 中国药房

OBJECTIVE To analyze the main components of Chelidonii Herba-Corydalis Rhizoma （CHCR）， and to predict pharmacodynamic substances against estrogen receptor （ER） -positive breast cancer and their potential targets and signaling pathways， followed by verifying experiments. METHODS The ethanol extract of CHCR was analyzed by ultra-performance liquid chromatography-quadrupole time-of-flight mass spectrometry （UPLC-Q-TOF-MS/MS）. The network pharmacology analysis was performed for the screened components. The network diagram of CHCR “active components-target-pathway” was constructed， and the enrichment pathway in vitro was validated. RESULTS A total of 58 chemical components were identified， including 57 alkaloids and 1 organic acid. A total of 38 active ingredients were screened from the network pharmacology， and 38 core targets were found in the protein-protein interaction network of “component-disease” intersection targets； 258 gene ontology entries and 137 Kyoto encyclopedia of genes and genomics pathways were obtained， mainly including estrogen signal pathway， phosphatidylinositol-3-kinase/protein kinase B （PI3K/Akt） signal pathway， etc. The results of validation test showed that the median inhibitory concentration of CHCR to MCF-7 cells was 693 μg/mL； 150， 300， 600 μg/mL CHCR could significantly reduce the expressions of phosphorylated PI3K， phosphorylated Akt， ERα protein and ESR1 mRNA （P＜0.01）. CONCLUSIONS The anti-ER-positive breast cancer effect of CHCR may be related to the regulation of ER and PI3K/Akt pathways， which has the characteristics of multi-component and multi-target effects.

Optimization of the Honey-stir-fired Technology of Chelidonium majus / 中国药房

OBJECTIVE：To optimize the honey-stir-fried technology of Chelidonium majus . METHODS ：Taking the mass ratio of water to honey ，the ratio of honey water to C. majus ，stir-fired temperature ，stir-fired time as the factors ，the total contents of chelidonine ，coptisine hydrochloride ，sanguinarine，berberine，chelerythrine as response values ，Box-Behnken response surface method was used to optimize the processing technology ，and valifation test was conducted. RESULTS ：The optimum process conditions were as follows the ratio of water to refined honey 1∶1.9（g/g），the ratio of honey water to C. majus 21∶100（g/g）， stir-fried temperature 122 ℃，stir-fried time 10.40 min. After 3 times of validation ，average total contents of 5 components was 10.37 mg/g（RSD＝0.23％），relative error of which with predicted value （10.39 mg/g）was 0.19％. CONCLUSIONS ：The optimized honey-stir-fried technology of C. majus is stable and feasible.

Isolation and identification of endophytic fungi from Chelidonium majus and their antifungal activity / 中国中药杂志

In order to find new source of antifungal agents, eleven cultivable endophytic fungi were isolated from the roots,stems and leaves of Chelidonium majus by traditional method. Seven of them were identified as Colletotrichum(L1, L2, L3, S1, S3, S4, S5), and three of them were identified as Fusarium(R1,R2,R3) by morphological features and molecular biological technology. The antifungal activity test showed that all the tested fungi displayed some inhibitory activity against five common plant pathogens(C. gloeosporioides, Curvularia lunata, Pyricularia oryza, Alternaria alternate and A. brassicae), and their inhibition rate of some test items were over 60%. Among them, R1, S2, S3 and S4 were more potent than others. This study enriches the understanding of endophytes from Ch. majus and provides a basis for the study of new microbial fungicides.

Study on antitumor molecular mechanism of Chelidonium majus based on network pharmacology / 中草药

Objective Chelidonium majus is applied to tumor therapy with good clinical effect and weak adverse effect. To explain the molecular mechanism of antitumor effect scientifically, the network pharmacology method was used to screen effective parts and major active components of C. majus and to construct the active compounds-targets network. Methods ADME calculation method was used to filtrate the active components of C. majus, and then the targets of the main active ingredients were collected by literature mining and multiple databases, and the targets of the compound were screened using the SysDT model. Besides, the compounds-targets network was constructed by Cytoscape software and network topology analysis was carried out. Biological information annotation databases (DAVID) was used to analyze the molecular function and biological pathway of the action targets. Results Alkaloids were the major active components of C. majus, 21 alkaloid components were screened out by ADME calculation method with 168 related targets, and 60 closely cancer-related pathways. Those pathways were integrated, with which a comprehensive C. majus antitumor pathway was constructed. According to the results of network topology analysis and ingredient correction results, it was speculated that chelerythrine, berberine and sanguinarine were the main active ingredients in C. majus, acting on the targets of PTGS2, SCN5A, F10, NCOA2, CHRM3, AR, TP5, CASP1/3/9, DRD1, MAPT, MAPK1, BLM, etc. Conclusion The antitumor activities of C. majus were mainly by inducing cell apoptosis and inhibiting cell proliferation, metastasis and invasion as phenotype intervention mode in network, thereby to exert antitumor activities and a certain central analgesic effect.

Stabilization of Chronic Lymphatic Leukemia with Amanita phalloides: Effect of Additional Chelidonium majus. Case Report.

Objectives: Amanita phalloides contains amanitin, inhibiting RNA polymerase II. Partial inhibition with amanitin influences tumor cell - but not normal cell - activity. A patient with diagnosed B-cell chronic lymphatic leukemia was treated successfully for eight years with Amanita phalloides. However, the necessary dose for stabilization of the disease increased during this time. In addition thrombocyte levels decreased, indicating bone marrow affection. Therefore additional regimen was necessary. Methods: Chelidonium majus contains alkaloids with cytostatic and cytotoxic potential. In addition to Amanita, Chelidonium was applied. Results: During treatment with Amanita and Chelidonium, leukocyte levels and lactate-dehydrogenase levels were roughly unaffected, meaning there is no strong effect on tumor growth of cells, and no observable cell destruction. Anyhow, thrombocyte levels increased after the Chelidonium treatment, indicating an effect in the bone marrow. Conclusion: Chelidonium majus can be useful during Amanita therapy as a pulse to regenerate bone marrow affection.

Chelidonium majus-Induced Acute Hepatitis / 이화의대지

The use of traditional folk remedies is increasing throughout Asia. Chelidonium majus, a popular herbal remedy, is used to treat abdominal pain caused by various gastrointestinal disorders, including gastric ulcer, gastritis, and biliary tract disease, because of its morphine-like effect. We encountered a 62-year-old woman with acute hepatitis, in which C. majus was suspected to be the etiological factor. The patient had taken high dose of C. majus extract for the preceding 60 days. The clinical context and the temporal association between the start of the herbal medicine treatment and her liver injury allowed us to attribute a causative role to C. majus. The diagnosis was confirmed by liver biopsy and the Council for International Organizations of Medical Sciences/Roussel Uclaf Causality Assessment Method (CIOMS/RUCAM) scale. After C. majus was discontinued, the liver function was restored to normal. In conclusion, because the use of phytotherapy is increasing, we wish to raise awareness of the potential adverse effects of C. majus.

The study of plants and minerals with wound-healing activities / Монголын Анагаах Ухаан

BackgroundThe works done during the research include: conducting photochemical study on the surface of the piece of land on which the medicinal herbs chosen as samples for the research grow; extracting dry infusion from plants; identifying main substance and antibacterial activity of dry infusion; conducting pilot pharmacological experiment with mineral samples.GoalBased on the results of these experiments, we aimed at finding out wound healing functions of Chelidonium majus. L, Stellerae chamaejasme.L etc, widely used in both conventional and modern medicine as well as of such minerals as Sinder, Zeolite, Tormohon, Baragshun after selecting from them.Materials and MethodsAlkaloid, a biologically active substance found in surface of plant land and dry infusion, was determined by titration method, alkaloids such as protopine and berberine by high performance liquid chromatography, coumarin and flavonoid by spectrophotometric method, the amount of infusible substance by scale method. The methodologies of Gatsura.N and Avtandilov.G.G were adopted to make artificial wound on skin and to heal a wound respectively.ResultsAs the research result shows, the surface of the area where Stellerae chamaejasme.L grow, contains 0.33% ±0.004 total coumarin, 0.19 % ±0.002 flavonoid and 37.14 % ±0.61 infusible substance while that of Chelidonium majus.L contains 0.19% ±0.003 total alkaloid, 0.12 % ±0.004 flavonoid, 0.09 % ±0.002 coumarin and 36.27%±0.74 infusible substance. After the infusion was extracted from Stellerae chamaejasme.L and Chelidonium majus.L through method of percolation with mixer, there were 16% and 14.5% dry substance remained in the infusions respectively. These figures were reduced to 12.6% and 11.4% after freezing them in -500C for 72 hours in dry freezing. The fact that total coumarin contained in dry infusion of Stellerae chamaejasme.L is 2.95% and protopine and berberine in that of Chelidonium majus.L, is 28 мг,% and 3.7 мг,% respectively meets the requirements for medicinal plant extracts. It was found during the pharmacological experiment of preparing 25% oil ointment composed of minerals including Sinder, Tormohon, Zeolite, Baragshun that zeolite was the highest effective mineral in healing a wound by wound index. Therefore, we chose zeolite as an ingredient of the wound ointment. Oil ointments of 6 variations with 5% and 10% content were prepared from the dry infusion as well as minerals of the study plants, and pilot pharmacological experiment was conducted on an experimental mouse that had an artificial wound. The result of the experiment proved that oil ointments with 5% content of Stellerae chamaejasme.L, Chelidonium majus.L and zeolite were more effective in healing the wound than others.ConclusionBy photochemical analysis, the chosen plants proved to be meeting the requirements for medicinal plants. Pilot pharmacological experiment showed that zeolite was the one that accelerated a wound healing process more efficiently than others. Oil ointments with 5% content of dry infusion and 5% of zeolite were effective in healing a wound quickly.

Efeito do Chelidonium majus D3 sobre a hipercolesterolemia experimentalmente induzida em coelhos / Effect of Chelidonium majus D3 on the experimentally induced hypercholesterolemia in rabbits

Introdução: A dislipidemia é um dos maiores fatores de risco para doenças cardiovasculares. Chelidonium majus é uma planta que tem possíveis efeitos sobre a colerese. Objetivo: Verificar a ação do Chelidonium majus D3 sobre a hipercolesterolemia induzida em coelhos. Metodologia: Utilizaram-se 13 coelhos Nova Zelândia brancos em ambiente controlado, recebendo ração hipercolesterolemiante, divididos em dois grupos: tratado e placebo. O grupo tratado recebeu dose via oral de Chelidonium majus D3 diluído em solução hidroalcoólica 30%, duas vezes por dia durante 30 dias, verificando-se os níveis de colesterol total, HDL-colesterol, triglicerídios e relação colesterol total / HDL-colesterol em ambos os grupos. O grupo-placebo recebeu apenas solução hidroalcoólica 30%. Foi utilizado o teste Mann-Whitney para análise dos dados. Resultados: Relacionandose os resultados das diferenças das medianas da coleta intermediária com a basal entre os grupos, obtiveram-se os seguintes resultados: colesterol total: 0,073; HDL-colesterol: 0,628; relação colesterol total / HDL-colesterol: 0,181; triglicerídios: 0,445. Entre a coleta final e a basal, verificaram-se entre os grupos os seguintes resultados: colesterol total: 0,628; HDL-colesterol: 0,366; relação colesterol total / HDL-colesterol: 0,035 (p < 0,05); triglicerídios: 0,035 (p < 0,05). Conclusão: Na amostra estudada não se verificou ação do Chelidonium majus como redutor do colesterol total ou estímulo à elevação do HDLcolesterol. Observou-se, no entanto, ação significativa sobre a redução dos triglicerídios e na redução da relação entre colesterol total e HDL-colesterol (AU)

Introduction: Dyslipidemia is one of the biggest risk factors for cardiovascular disease. Chelidonium majus is a plant that has possible action on choleresis. Objective: Verify the action of Chelidonium majus D3 on the induced hypercholesterolemia in rabbits. Methodology: Were used 13 white rabbits New Zeland in controlled environment, receiving hypercholesterolemic feeding, divided in two groups: treated and placebo. The treated group received oral dose of Chelidonium majus D3 diluted in hydro alcoholic solution 30%, twice a day during 30 days, verifying the total cholesterol, HDL-cholesterol and triglycerides levels and relation total cholesterol / HDL-cholesterol in both groups. The placebo group receveid just hydro alcoholic solution 30%. The Mann-Whitney Test was used for analysis of the data. Results: Becoming related the results of the differences of medians from the intermediate collection with the basal one between groups, we got the following results: Total Cholesterol: 0,073; HDL-cholesterol: 0,628; Relation Total Cholesterol / HDL-cholesterol: 0,181; Triglycerides: 0,445. Between the final collection and the basal one, was verified the following results between groups: Total Cholesterol: 0,628; HDL-cholesterol: 0,366; Relation Total Cholesterol / HDL-cholesterol: 0,035 (p<0,05); Triglycerides: 0,035(p<0,05). Conclusion: In this sample, the action of Chelidonium majus D3 in reducing the total cholesterol or stimulating the rising of HDL-cholesterol was not verified. It was observed, however, significant action on the reduction of the triglycerides and in the reduction of the relation between Total Cholesterol and HDL-cholesterol (AU)